Cigna Corporation cash flow to debt ratio of 30.52% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Cigna Corporation's free cash flow has decreased 6.34% from $8.96B last year to $8.39B, signaling decreasing performance

Cigna Corporation's debt to equity ratio is 0.75, which means that the company's assets are unhealthy financed, signaling financial risk.

Cigna Corporation's debt has decreased relative to shareholder equity from 0.78 last year to 0.75 today, signaling strengthened financials

Cigna Corporation has a net debt to EBITDA ratio of 2.05x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Cigna Corporation's interest coverage ratio of 7.00 indicates that earnings with good margin can cover interest payments on company debt

Cigna Corporation's profit margin has increased (63.51%) in the last year from 1.39% to 2.27%, signaling increasing performance

Cigna Corporation's short-term liabilities of $56.34B exceed its short-term assets of $47.81B, signaling financial risk

Cigna Corporation's return on assets of 4.08% is lower than the 5.00% threshold, indicating inefficient asset utilization

Cigna Corporation's return on equity of 15.24%, is higher than 15.00%, indicating good performance

Cigna Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Cigna Corporation had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Cigna Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Cigna Corporation has a free cash flow yield of 11.40%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Cigna Corporation's yearly earnings has increased 73.47% since last year from $3.43B to $5.96B, signaling increasing performance

Cigna Corporation's yearly revenue has increased 11.26% since last year from $247.12B to $274.95B, signaling increasing performance

ROIC 7.69% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Cigna Corporation's 3-year revenue CAGR of 15.06% is positive, indicating growing revenue over the past 3 years

Cigna Corporation had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Cigna Corporation had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Cigna Corporation is overvalued relative to its fair value price of 248.98 based on Discounted Cash Flow model

Cigna Corporation has an earnings yield of 8.73%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Cigna Corporation is overvalued relative to its fair value price of 215.12 based on EBITDA multiple model

Cigna Corporation has an EV/EBITDA ratio of 8.39x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Cigna Corporation is undervalued relative to its fair value price of 931.96 based on Earnings Fair Value model

Cigna Corporation's earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.

Cigna Corporation has a price-to-book ratio of 1.71x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Cigna Corporation has a price-to-sales ratio of 0.26x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue